Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Development of a Cellular and Animal Model for Infantile Haemangioma More
Plasmid DNA Vectors that Integrate into Host Chromosomal DNA in vivo: Stable Gene Transfer for Biological Studies and Gene Therapy More
Invasive Trophoblast Antigen-2: A Biochemical Test for Identifying Pregnancies with Down Syndrome Foetus More
Diagnosis of Smith-Lemli-Opitz Syndrome: A Novel Non-invasive Assay More
Phase II Clinical Development of Cx501: Chimeric Skin for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) More
Development of Retinitis Pigmentosa Animal Models More
Phase II Clinical Development of HPN-100 for the Treatment of Urea Cycle Disorders More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Oct 2011 - 27 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 330 pages - $1,495
Nov 2010 - 527 pages - $1,495
Nov 2011 - 7 pages - $3,835
Apr 2011 - 26 pages - $500
Feb 2011 - 42 pages - $5,700
Dec 2010 - 22 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Birth defects
- Blood clotting disorders
- Fabry's disease
- Gaucher's disease
- Genetic disorder (other)
- Hunter's syndrome
- Huntington's disease
- Kawasaki disease
- Klinefelter's syndrome
- Phenylketonuria
- Severe combined immunodeficiency
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us